ASCO 2020 | Highlights in multiple myeloma at ASCO 2020
Suzanne Lentzsch
Suzanne Lentzsch, MD, PhD, Columbia University, New York, NY, USA, takes us through a selection of the most important studies presented at ASCO 2020 in multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Related videos
3:08 Defining newly diagnosed high-risk MM
Joshua Richter
3:12 Allogeneic HSCT in patients with high-risk myeloma
Sergio Giralt
3:47 VOD: treatment and prevention
Sergio Giralt
4:41 DREAMM-3: belantamab mafodotin vs pom/dex for R/R myeloma
Katja Weisel
4:39 ENDURANCE: RVD vs KrD for myeloma
Paul Richardson
